Executive Overview In a significant vote of confidence from its existing investor base, biopharmaceutical innovator Airway Therapeutics has successfully closed...
Executive Overview In a milestone achievement for chemical biology and pharmacology, an international research team has finally unlocked a biochemical...
Executive Overview In a development that highlights the vast potential of drug repurposing in modern oncology, researchers at the Dartmouth...
Executive Overview With over a quarter of all Type 2 diabetes patients globally relying on GLP-1 receptor agonists—a revolutionary class...
Executive Overview The boundary lines separating metabolic medicine and neurology are blurring at an unprecedented pace. For decades, type 2...
Executive Overview In a significant strategic expansion of its oncology clinical development pipeline, Summit Therapeutics has announced the initiation of...
Executive Overview In a decisive move emblematic of the hyper-selective, risk-averse climate currently dominating the biotech sector, Philadelphia-based Context Therapeutics...
Executive Overview In a significant milestone for modern oncology and targeted drug delivery, biopharmaceutical innovator SystImmune has officially dosed the...
